BLADDER FIBROSIS

BLADDER FIBROSIS was reported 40 times

BLADDER FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cephalosporin Antibacterial [EPC] 1 0.0001
1 Nonergot Dopamine Agonist [EPC] 1 0.0001
2 Vitamin D3 Analog [EPC] 1 0.0000
3 Alkaloid [EPC] 1 0.0000
4 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2 0.0000
5 Penem Antibacterial [EPC] 1 0.0000
6 Pyridone [EPC] 1 0.0000
7 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
8 Muscle Relaxant [EPC] 1 0.0000
9 Acetylcholine Release Inhibitor [EPC] 2 0.0000
10 Azole Antifungal [EPC] 3 0.0000
11 Methylxanthine [EPC] 1 0.0000
12 Alkylating Drug [EPC] 4 0.0000
13 Calcium [EPC] 2 0.0000
14 Central Nervous System Stimulant [EPC] 1 0.0000
15 Platinum-based Drug [EPC] 3 0.0000
16 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
17 Aminosalicylate [EPC] 1 0.0000
18 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
19 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
20 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
21 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
22 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
23 beta-Adrenergic Blocker [EPC] 2 0.0000
24 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
25 Janus Kinase Inhibitor [EPC] 1 0.0000
26 Microtubule Inhibitor [EPC] 1 0.0000
27 Estrogen [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 3 0.0000
29 Vitamin C [EPC] 2 0.0000
30 Corticosteroid [EPC] 6 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
32 Kinase Inhibitor [EPC] 2 0.0000
33 Progestin [EPC] 1 0.0000
34 Vitamin D [EPC] 1 0.0000
35 Vitamin B12 [EPC] 1 0.0000
36 Benzodiazepine [EPC] 2 0.0000
37 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
38 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
39 Insulin Analog [EPC] 1 0.0000
40 Atypical Antipsychotic [EPC] 1 0.0000
41 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
42 Thalidomide Analog [EPC] 1 0.0000